Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes

Gut

Volumn 62, Issue 10, 2013, Pages 1456-1465

  Hughes, Patrick A ^a,b   Harrington, Andrea M ^a   Castro, Joel ^a   Liebregts, Tobias ^a,c   Adam, Birgit ^a,c   Grasby, Dallas J ^a   Isaacs, Nicole J ^a   Maldeniya, Lochana ^a   Martin, Chris M ^a   Persson, Jenny ^a   Andrews, Jane M ^a   Holtmann, Gerald ^a   Ashley Blackshaw, L ^a,d   Brierley, Stuart M ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; OPIATE; SODIUM CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME; CONTROLLED STUDY; DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN CELL; HYPERSENSITIVITY; IMMUNE SYSTEM; IMMUNOPATHOLOGY; IRRITABLE COLON; MALE; MOUSE; NERVE EXCITABILITY; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSORY SYSTEM;

2,4,6-TRINITROBENZENE SULPHONIC ACID; CYTOKINE; FUNCTIONAL BOWEL DISORDER; FUNCTIONAL DYSPEPSIA; GASTRO-OESOPHAGEAL REFLUX DISEASE; HELICOBACTER PYLORI-EPIDEMIOLOGY; IRRITABLE BOWEL SYNDROME; LOWER OESOPHAGEAL SPHINCTER; NERVE-GUT INTERACTIONS; NEUROGASTROENTEROLOGY; PAIN; REAL TIME PCR; SENSORY NEURONS; VISCERAL HYPERSENSITIVITY; VISCERAL NOCICEPTION;

ADULT; ANIMALS; BETA-ENDORPHIN; CASE-CONTROL STUDIES; CELLS, CULTURED; COLON; CONSTIPATION; CULTURE MEDIA, CONDITIONED; CYTOKINES; DIARRHEA; FEMALE; GANGLIA, SPINAL; HUMANS; IRRITABLE BOWEL SYNDROME; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MIDDLE AGED; NEUROIMMUNOMODULATION; NEURONS, AFFERENT; PAIN; RECEPTORS, CYTOKINE;

EID: 84884283276     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-301856     Document Type: Article

References (53)

1. Gralnek IM, Hays RD, Kilbourne A, et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119:654-60.
2. Drossman DA, Camilleri M, Mayer EA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123:2108-31. (Pubitemid 35408332)
3. Talley NJ, Zinsmeister AR, Van Dyke C, et al. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991;101:927-34.
4. Spiller R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007;56:1770-98. (Pubitemid 350206308)
5. Drossman DA, Creed FH, Olden KW, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gut 1999;45(Suppl 2): II25-30. (Pubitemid 29434809)
6. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009;136:1979-88.
7. Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003;98:1578-83. (Pubitemid 36875351)
8. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-6. (Pubitemid 29119338)
9. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-11.
10. Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004;53:1096-101.
11. Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126:693-702. (Pubitemid 38298317)
12. Cenac N, Andrews CN, Holzhausen M, et al. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 2007;117:636-47. (Pubitemid 46348522)
13. Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002;122:1778-83. (Pubitemid 34651421)
14. Cremon C, Gargano L, Morselli-Labate AM, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 2009;104:392-400.
15. Tornblom H, Lindberg G, Nyberg B, et al. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002;123:1972-9. (Pubitemid 35408321)
16. Ohman L, Isaksson S, Lindmark AC, et al. T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol 2009;104:1205-12.
17. Ohman L, Isaksson S, Lundgren A, et al. A controlled study of colonic immune activity and beta7+ blood T lymphocytes in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2005;3:980-6. (Pubitemid 41415745)
18. Gonsalkorale WM, Perrey C, Pravica V, et al. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut 2003;52:91-3. (Pubitemid 36020772)
19. Kindt S, Van Oudenhove L, Broekaert D, et al. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil 2009;21:389-98.
20. Liebregts T, Adam B, Bredack C, et al. Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia. Am J Gastroenterol 2011;106:1089-98.
21. Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007;132:913-20. (Pubitemid 46440872)
22. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541-51. (Pubitemid 40585355)
23. Scully P, McKernan DP, Keohane J, et al. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol 2010;105:2235-43.
24. Van der Veek PP, Van Den Berg M, De Kroon YE, et al. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome. Am J Gastroenterol 2005;100:2510-16.
25. Ohman L, Simren M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010;7:163-73.
26. Brierley SM, Jones RC 3rd, Gebhart GF, et al. Splanchnic and pelvic mechanosensory afferents signal different qualities of colonic stimuli in mice. Gastroenterology 2004;127:166-78. (Pubitemid 38962285)
27. Hughes PA, Brierley SM, Martin CM, et al. Post-inflammatory colonic afferent sensitisation: different subtypes, different pathways and different time courses. Gut 2009;58:1333-41.
28. Hughes PA, Brierley SM, Blackshaw LA. Post-inflammatory modification of colonic afferent mechanosensitivity. Clin Exp Pharmacol Physiol 2009;36:1034-40.
29. Barbara G, Wang B, Stanghellini V, et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007;132:26-37. (Pubitemid 46108761)
30. Buhner S, Li Q, Vignali S, et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 2009;137:1425-34.
31. Cremon C, Carini G, Wang B, et al. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. Am J Gastroenterol 2011;106:1290-8.
32. Hughes PA, Brierley SM, Martin CM, et al. TRPV1-expressing sensory fibres and IBS: links with immune function. Gut 2009;58:465-6.
33. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45(Suppl 2): II43-7. (Pubitemid 29434812)
34. Brierley SM, Hughes PA, Page AJ, et al. The ion channel TRPA1 is required for normal mechanosensation and is modulated by algesic stimuli. Gastroenterology 2009;137:2084-95.e3.
35. Brierley SM, Page AJ, Hughes PA, et al. Selective role for TRPV4 ion channels in visceral sensory pathways. Gastroenterology 2008;134:2059-69. (Pubitemid 351783249)
36. Harrington AM, Hughes PA, Martin CM, et al. A novel role for TRPM8 in visceral afferent function. Pain 2011;152:1459-68.
37. Hughes PA, Brierley SM, Young RL, et al. Localization and comparative analysis of acid-sensing ion channel (ASIC1, 2, and 3) mRNA expression in mouse colonic sensory neurons within thoracolumbar dorsal root ganglia. J Comp Neurol 2007;500:863-75. (Pubitemid 46137723)
38. Ibeakanma C, Vanner S. TNFalpha is a key mediator of the pronociceptive effects of mucosal supernatant from human ulcerative colitis on colonic DRG neurons. Gut 2010;59:612-21.
39. Ozaktay AC, Cavanaugh JM, Asik I, et al. Dorsal root sensitivity to interleukin-1 beta, interleukin-6 and tumor necrosis factor in rats. Eur Spine J 2002;11:467-75. (Pubitemid 35232017)
40. Jin X, Gereau RW 4th. Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J Neurosci 2006;26:246-55. (Pubitemid 43089538)
41. Flatters SJ, Fox AJ, Dickenson AH. Spinal interleukin-6 (IL-6) inhibits nociceptive transmission following neuropathy. Brain Res 2003;984:54-62. (Pubitemid 36976794)
42. Binshtok AM, Wang H, Zimmermann K, et al. Nociceptors are interleukin-1beta sensors. J Neurosci 2008;28:14062-73.
43. Obreja O, Rathee PK, Lips KS, et al. IL-1 beta potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C. FASEB J 2002;16:1497-503. (Pubitemid 35154632)
44. Liu L, Yang TM, Liedtke W, et al. Chronic IL-1beta signaling potentiates voltage-dependent sodium currents in trigeminal nociceptive neurons. J Neurophysiol 2006;95:1478-90.
45. Hagenacker T, Czeschik JC, Schafers M, et al. Sensitization of voltage activated calcium channel currents for capsaicin in nociceptive neurons by tumor-necrosis-factor-alpha. Brain Res Bull 2010;81:157-63.
46. Li Y, Ji A, Weihe E, et al. Cell-specific expression and lipopolysaccharide-induced regulation of tumor necrosis factor alpha (TNFalpha) and TNF receptors in rat dorsal root ganglion. J Neurosci 2004;24:9623-31. (Pubitemid 39441516)
47. Schmidt R, Kleggetveit IP, Namer B, et al. Double spikes to single electrical stimulation correlates to spontaneous activity of nociceptors in painful neuropathy patients. Pain 2012;153:391-8.
48. Brierley SM, Castro J, Harrington AM, et al. TRPA1 contributes to specific mechanically activated currents and sensory neuron mechanical hypersensitivity. J Physiol 2011;589:3575-93.
49. Kieffer BL, Evans CJ. Opioid receptors: from binding sites to visible molecules in vivo. Neuropharmacology 2009;56(Suppl 1):205-12.
50. Verma-Gandhu M, Bercik P, Motomura Y, et al. CD4+ T-cell modulation of visceral nociception in mice. Gastroenterology 2006;130:1721-8. (Pubitemid 43668870)
51. Mousa SA, Shakibaei M, Sitte N, et al. Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 2004;145:1331-41. (Pubitemid 38281017)
52. Klooker TK, Braak B, Koopman KE, et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 2010;59:1213-21.
53. Dunlop SP, Jenkins D, Neal KR, et al. Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2003;18:77-84. (Pubitemid 36897983)